Weightloss Injections

We provide two types of weight loss injections: Saxenda and Ozempic. Extensively studied in clinical trials, both Saxenda and Ozempic have demonstrated their safety and effectiveness. These injections have proven to be notably more successful than relying solely on diet and exercise for weight loss.


Lose weight and feel great with our medical weight loss program!

Saxenda (Liraglutide)

Saxenda (Liraglutide)

Saxenda is an injectable medication designed for once-daily use. Its primary function is to regulate appetite and cravings by reducing stomach emptying and influencing the brain's appetite control center. Clinically proven to be effective, Saxenda has helped numerous individuals attain substantial weight loss. Additionally, it has received approval for treating obesity and managing weight.

How to take: Daily pen injection
Starting Dosage: 0.6 mg daily
Price: From £299 per month
Discount: Save 30% on your first month
Order Now
Ozempic (Semaglutide)

Ozempic (Semaglutide)

Ozempic is a once-weekly injectable medication that aids in appetite and cravings management by regulating stomach emptying and influencing the brain's appetite control center. Its effectiveness in weight loss has been clinically validated, and it is additionally utilized in the treatment of type 2 diabetes.

How to take: Weekly pen injection

Starting Dosage: 0.25mg week

Price: From £295 per month (including consultation)

Discount: Save 10% on your first 3 months

Order Now

Who are Eligible?

Our team of medical professionals will collaborate with you to identify the most suitable treatment option tailored to your specific needs and objectives.

Eligibility Criteria:

  • BMI ≥ 30 kg/m2
  • BMI ≥ 27 kg/m2 with weight-related comorbidities.

Who are not Eligible?

  • Patients under 18 years of age
  • Pregnant or breastfeeding women
  • Patients diagnosed with eating disorders
  • Those with active diabetic gastroparesis
  • Those with active inflammatory bowel disease
  • Individuals with decompensated congestive heart failure
  • Severe renal impairment (Kidney failure)
  • Severe hepatic impairment (Liver failure)
  • Individuals with a family history of medullary thyroid carcinoma.